Long-term immunogenicity of preservative
β
Pierre Van Damme; Frank von Sonnenburg; Christoph Hatz; Bernard Hoet; Inge Lefev
π
Article
π
2009
π
John Wiley and Sons
π
English
β 201 KB
## Abstract Vaccination with recombinant hepatitis B vaccines is highly effective in preventing hepatitis B infection. Recently, a preservativeβfree (PF) formulation of hepatitis B vaccine [GlaxoSmithKline (GSK) Biologicals, Rixensart, Belgium] has been licensed. The immunogenicity of the PF hepati